These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 17356336)

  • 1. Neuropsychologic assessment of patients with advanced Parkinson disease submitted to extradural motor cortex stimulation.
    Munno D; Caporale S; Zullo G; Sterpone S; Malfatto A; Zeme S; Pagni CA
    Cogn Behav Neurol; 2007 Mar; 20(1):1-6. PubMed ID: 17356336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of bilateral subthalamic nucleus deep brain stimulation (STN DBS) on cognition in Parkinson disease.
    Heo JH; Lee KM; Paek SH; Kim MJ; Lee JY; Kim JY; Cho SY; Lim YH; Kim MR; Jeong SY; Jeon BS
    J Neurol Sci; 2008 Oct; 273(1-2):19-24. PubMed ID: 18640690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic extradural cortical stimulation for Parkinson's Disease: report of six cases and review of the literature.
    Gutiérrez JC; Seijo FJ; Alvarez Vega MA; Fernández González F; Lozano Aragoneses B; Blázquez M
    Clin Neurol Neurosurg; 2009 Oct; 111(8):703-7. PubMed ID: 19604625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short and long-term motor and cognitive outcome of staged bilateral pallidotomy: a retrospective analysis.
    York MK; Lai EC; Jankovic J; Macias A; Atassi F; Levin HS; Grossman RG
    Acta Neurochir (Wien); 2007; 149(9):857-66; discussion 866. PubMed ID: 17624489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuro-psychiatric therapy during chronic subthalamic stimulation in Parkinson's disease.
    Zibetti M; Pesare M; Cinquepalmi A; Rosso M; Castelli L; Rizzi L; Bergamasco B; Lanotte M; Lopiano L
    Parkinsonism Relat Disord; 2009 Feb; 15(2):128-33. PubMed ID: 18515169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropsychological and quality of life changes following unilateral thalamic deep brain stimulation in Parkinson's disease: a one-year follow-up.
    Woods SP; Fields JA; Lyons KE; Koller WC; Wilkinson SB; Pahwa R; Tröster AI
    Acta Neurochir (Wien); 2001 Dec; 143(12):1273-7; discussion 1278. PubMed ID: 11810392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive impairment in incident, untreated Parkinson disease: the Norwegian ParkWest study.
    Aarsland D; Brønnick K; Larsen JP; Tysnes OB; Alves G;
    Neurology; 2009 Mar; 72(13):1121-6. PubMed ID: 19020293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A program for neuropsychological investigation of deep brain stimulation (PNIDBS) in movement disorder patients: development, feasibility, and preliminary data.
    Morrison CE; Borod JC; Brin MF; Raskin SA; Germano IM; Weisz DJ; Olanow CW
    Neuropsychiatry Neuropsychol Behav Neurol; 2000 Jul; 13(3):204-19. PubMed ID: 10910093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Functional electrical stimulation effect on the motor performances in Parkinsonian patients].
    Popa L; Alexa D; Rotar A; Popescu CD
    Rev Med Chir Soc Med Nat Iasi; 2012; 116(2):436-41. PubMed ID: 23077933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of DBS, premotor rTMS, and levodopa on motor function and silent period in advanced Parkinson's disease.
    Bäumer T; Hidding U; Hamel W; Buhmann C; Moll CK; Gerloff C; Orth M; Siebner HR; Münchau A
    Mov Disord; 2009 Apr; 24(5):672-6. PubMed ID: 19185021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurocognitive and clinical predictors of functional outcome in patients with schizophrenia and bipolar I disorder at one-year follow-up.
    Tabarés-Seisdedos R; Balanzá-Martínez V; Sánchez-Moreno J; Martinez-Aran A; Salazar-Fraile J; Selva-Vera G; Rubio C; Mata I; Gómez-Beneyto M; Vieta E
    J Affect Disord; 2008 Aug; 109(3):286-99. PubMed ID: 18289698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional ability correlates with cognitive impairment in Parkinson's disease and Alzheimer's disease.
    Sabbagh MN; Lahti T; Connor DJ; Caviness JN; Shill H; Vedders L; Mahant P; Samanta J; Burns RS; Evidente VG; Driver-Dunckley E; Reisberg B; Bircea S; Adler CH
    Dement Geriatr Cogn Disord; 2007; 24(5):327-34. PubMed ID: 17851237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Depression impairs executive functioning in Parkinson disease patients with low educational level.
    Kummer A; Harsányi E; Dias FM; Cardoso F; Caramelli P; Teixeira AL
    Cogn Behav Neurol; 2009 Sep; 22(3):167-72. PubMed ID: 19741326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Neuropsychologic outcome after bilateral pallidotomy in patients with Parkinson disease].
    Kosztolányi P; Kállai J; Balás I; Karádi K; Dóczi T
    Ideggyogy Sz; 2002 Jul; 55(7-8):263-7. PubMed ID: 12201234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Affective symptoms and cognitive functions in Parkinson's disease.
    Poletti M; De Rosa A; Bonuccelli U
    J Neurol Sci; 2012 Jun; 317(1-2):97-102. PubMed ID: 22503136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Educational level as a modulator of cognitive performance and neuropsychyatric features in Parkinson disease.
    Cohen OS; Vakil E; Tanne D; Nitsan Z; Schwartz R; Hassin-Baer S
    Cogn Behav Neurol; 2007 Mar; 20(1):68-72. PubMed ID: 17356347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive characteristics associated with mild cognitive impairment in Parkinson's disease.
    McKinlay A; Grace RC; Dalrymple-Alford JC; Roger D
    Dement Geriatr Cogn Disord; 2009; 28(2):121-9. PubMed ID: 19690414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-frequency rTMS over the supplementary motor area for treatment of Parkinson's disease.
    Hamada M; Ugawa Y; Tsuji S;
    Mov Disord; 2008 Aug; 23(11):1524-31. PubMed ID: 18548577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Rasagiline in daily clinical use. Results of a treatment study of Parkinson patients with a combination treatment].
    Jost WH; Klasser M; Reichmann H
    Fortschr Neurol Psychiatr; 2008 Oct; 76(10):594-9. PubMed ID: 18833504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.